Home
About
Overview
Sharing Data
ORCID
Help
History (27)
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Kloeckera
Therapeutic Uses
Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.
Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors. Virology. 2011 Jun 20; 415(1):56-68.
View in:
PubMed
subject areas
Animals
Anti-HIV Agents
Astrocytes
Cell Death
Cell Line
Gene Expression
Gene Knockdown Techniques
Glycogen Synthase Kinase 3
Glycogen Synthase Kinase 3 beta
High-Throughput Screening Assays
HIV-1
Humans
Indoles
Macrophages
Neuroprotective Agents
Neurotoxins
Oximes
Polymerase Chain Reaction
Rats
tat Gene Products, Human Immunodeficiency Virus
Transcription, Genetic
Virus Replication
authors with profiles
Lena Al-Harthi